At the Limits Multiple Sclerosis 2023

10 $

+ Include: 13 videos + 1 pdf, size: 5.61 GB

+ Target Audience: multiple sclerosis specialists, neurologists, immunologists, neurophysiologists

Description

+ Include: 13 videos + 1 pdf, size: 5.61 GB

+ Target Audience: multiple sclerosis specialists, neurologists, immunologists, neurophysiologists

+ Sample video: contact me for sample video

+ Information:

The Royal College of Physicians, London

Tuesday, 26 & Wednesday, 27 September 2023

About the event

The 6th Annual MS  conference is a two-day medical education meeting which brings together a notable faculty of globally acknowledged MS experts who will consider new discoveries and therapies at the limits of MS treatments.

Audience: Multiple Sclerosis Specialists, Neurologists, Rehabilitation Specialists, Immunologists, Neurophysiologists, Scientists, Researchers.

Funders

Multiple Sclerosis at the Limits is supported by way of grants or sponsorship from the pharmaceutical industry. Our supporters have no involvement in the organisation of this event, or the selection of speakers or topics which are handled entirely independently by the event Chairs. Supporters are invited to send a delegation of senior company representatives to attend, and their role is simply to continue building the crucial understanding between academia and industry in a scientific setting. Full disclosure of contacted supporters will appear on the event website and be available at the venue during the event.

 

+ Topics:

Multiple Sclerosisÿat the Limits.pdf
Associate Professor M Isabel Leite – Long-term treatment of NMOSD – what do we need to know to make meaningful decisions-.mp4
Debate – DMT’s for all at diagnosis.mp4
Dirk Smeets – Demystifying AI and embedding it into clinical practice.mp4
Dr Arman Eshaghi – Redefining disease phenotyping in MS – basic science.mp4
Panel discussion – Emerging therapies in MS.mp4
Professor Alberto Ascherio – EBV in MS – still in focus, or soon forgotten (again)-.mp4
Professor Anat Achiron – DMT in newly diagnosed people with MS – coaching or coaxing.mp4
Professor David Baker – Beyond B-Cells – selective targeting of B-cell subpopulations.mp4
Professor Francisco J. Quintana – Cell-Cell signalling pathways- microglia and activated astrocytes.mp4
Professor Gavin Giovannoni – Redefining disease cell-typing in MS – clinical.mp4
Professor Jacqueline Palace – Long-term treatment of MOG AD – what do we need to know to make meaningful decisions.mp4
Professor Magd Zakaria – Treating MS Globally – the challenge of equity in MS care.mp4
Univ. Prof. Dr. Med. Heinz Wiendl – Immunopathogenic Mechanisms.mp4

Reviews

There are no reviews yet.

Be the first to review “At the Limits Multiple Sclerosis 2023”

Your email address will not be published. Required fields are marked *